Sign in
4

Changes in Ownership

RenovoRx, Inc. Filed Acc 0001209191-22-018488

Options or other derivatives

  • Director acquired 4,582 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Macfarlane K. Angela Director 2022-03-10 Grant or award · Stock option (right to buy) −4,582 4,582 D
Loading xslF345X03/doc4.xml…